Keywords: USA, HHS, SACGHS, Patents, Gene patents, Genetics, BIO

US HHS advisory group SACGHS’ proposals to limit gene patent draws fire from industry

Article | 8 February 2010

A US government committee at the Department Health and Human Services - Secretary’s Advisory Committee on Genetics, Health and Society (SACGHS) – last Friday voted to advise HHS Secretary Kathleen Sebelius to limit the ability of holders of gene patents to keep others from using those genes for diagnostic and research purposes.

C Enjoying this article? To continue reading you need to login, take a FREE trial or subscribe.

FREE unlimited, no obligation access to The Pharma Letter website for 30 days, normally worth Ł60!

Sign up in less than 60 seconds...no payment needed

Want to read the full article?
Take a 30 day FREE Trial worth Ł60

Take a no obligations 30 day trial.
Only one trial per user. Find out more details

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in